Skip to content

Robotic-assisted Training After Upper Arm Fracture

Robotic-assisted Training After Upper Arm Fracture - a Multicentre, Controlled and Randomized Intervention Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03100201
Acronym
RASTA
Enrollment
48
Registered
2017-04-04
Start date
2016-02-15
Completion date
2019-12-01
Last updated
2020-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Injury

Keywords

robotic-assisted rehabilitation, humeral fracture, randomised controlled study

Brief summary

In this study, patients with upper arm fracture will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks on the injured arm in addition to conventional physio- and occupational therapy. The supportive treatment and execution of specific exercises on the Armeo®Spring should lead to improved recovery of function and mobility of the upper arm compared to conservatively treated patients.

Detailed description

60 Patients aged between 35 and 70 years with proximal humeral fracture and surgical treatment will be recruited in three different clinics in Germany and randomised into an intervention and a control group. Participants will be assessed before randomisation and followed up after completing an intervention period of 3 weeks and additionally after 3, 6 and 12 months. Baseline assessment will assess cognition (SOMC), level of pain in the affected arm, ability to work, gait speed (10m walk), disability of the arm, shoulder and hand (DASH), as well as the range of motion of the affected arm (goniometer measurement), visual acuity and motor function of orthopaedic patients (WMFT-O). Clinical follow up directly after intervention will assess disability of the arm, shoulder and hand (DASH), the range of motion and motor function (WMFT-O). Primary outcome parameter will be the DASH and secondary outcome parameter will be the WMFT-O. The long-term results will be assessed prospectively by a postal follow-up. All patients will receive conventional occupational- and physiotherapy. The intervention group will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks.

Interventions

OTHERIntervention Armeo®Spring

The robotic-assisted training will be performed using the clinically evaluated Armeo®Spring medical device (Hocoma AG, Zurich, Switzerland). By means of a sensory orthosis, arm movements will be supported and transmitted to a computer system and visually shown on a screen.

OTHERControl Group

The control group will receive conventional occupational- and physiotherapy over 3 weeks

Sponsors

BG Unfallklinik Murnau
CollaboratorOTHER
Berufsgenossenschaftliche Unfallklinik Ludwigshafen
CollaboratorOTHER
Deutsche Gesetzliche Unfallversicherung (DGUV)
CollaboratorUNKNOWN
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Patients will be recruited in three different clinics in Germany and randomised into an intervention and a control group. All patients will receive conventional occupational- and physiotherapy. The intervention group will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks.

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* surgical treatment of the shoulder joint after upper arm fracture classified as type AO 11 * movement-stable fracture * Inclusion between the fourth and the seventh week after surgery

Exclusion criteria

* limited cognition as defined by a score in Short-Orientation-Memory-Concentration Test (SOMC) less than 10 points * inadequate level of pain during movement of the affected shoulder joint (pain score \>5 on a visual analogue pain scale) * strongly limited vision or hearing * heart failure (New York Heart Association stage III-IV) or COPD (Chronic Obstructive Pulmonary Disease) Gold stage III-IV * walking speed \<0.8m/sec * isolated tuberculum majus fracture of the humerus (AO 11, A1) * fractures with involvement of the glenoid cavity * double fractures * injury of the plexus or the axillaris nerve

Design outcomes

Primary

MeasureTime frameDescription
Change in disability of the arm, shoulder and hand (DASH)DASH will be assessed before randomisation and followed up after completing an intervention period of 3 weeks and additionally after 3, 6 and 12 months for assessing the changesubjective questionnaire for assessing the disability of the arm, shoulder and hand

Secondary

MeasureTime frameDescription
Change in the WMFT-OWMFT will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the changeWMFT-O is an objective test for assessing the disability of the shoulder
Change in ROMROM will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the changea goniometer-based measurement of the active range of motion (ROM) of the shoulder joint
Change in grip strengthgrip strength will be assessed before randomisation and followed up after completing an intervention period of 3 weeks for assessing the changemeasurement of the grip strength using the Jamar dynamometer

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026